Survival cancers cdk6. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy14

Cell Line, Tumor Tumor Cells, Cultured Cell Line Cells, Cultured Neoplastic Stem Cells Breast HCT116 Cells Prostate Lymph Nodes Cell Nucleus HeLa Cells Epithelial Cells HT29 Cells MCF-7 Cells

Organisms6

Mice, Nude Mice, Inbred C57BL Mice, Inbred BALB C Mice, SCID Mice, Transgenic Mice, Knockout

Diseases46

Breast Neoplasms Lung Neoplasms Ovarian Neoplasms Prostatic Neoplasms Neoplasm Metastasis Stomach Neoplasms Colonic Neoplasms Neoplasm Invasiveness Neoplasms Pancreatic Neoplasms Neoplasm Recurrence, Local Disease Progression Carcinoma, Squamous Cell Carcinoma, Non-Small-Cell Lung Colorectal Neoplasms Carcinoma Adenocarcinoma Urinary Bladder Neoplasms Genetic Predisposition to Disease Liver Neoplasms Uterine Cervical Neoplasms Rectal Neoplasms Cell Transformation, Neoplastic Esophageal Neoplasms Endometrial Neoplasms Bone Neoplasms Head and Neck Neoplasms Skin Neoplasms Brain Neoplasms Melanoma Carcinoma, Small Cell Disease Models, Animal Mouth Neoplasms Neovascularization, Pathologic Neoplasms, Hormone-Dependent Neoplasms, Second Primary Kidney Neoplasms Gastrointestinal Neoplasms Recurrence Carcinoma, Hepatocellular Neoplasms, Radiation-Induced Genital Neoplasms, Female Mammary Neoplasms, Experimental Precancerous Conditions Thyroid Neoplasms Neoplasms, Glandular and Epithelial

Chemicals and Drugs67

Cyclin-Dependent Kinases Cyclin-Dependent Kinase 2 Cyclin-Dependent Kinase 5 Cyclin-Dependent Kinase 4 Antineoplastic Agents Neoplasm Proteins CDC2-CDC28 Kinases Tumor Markers, Biological Cancer Vaccines RNA, Messenger Protein-Serine-Threonine Kinases Cyclin-Dependent Kinase 6 Cyclins CDC2 Protein Kinase Cell Cycle Proteins RNA, Small Interfering Proto-Oncogene Proteins Tumor Suppressor Protein p53 Cisplatin Tumor Suppressor Proteins Fluorouracil Receptors, Estrogen Receptor, erbB-2 Cyclin-Dependent Kinase Inhibitor p27 DNA, Neoplasm Cyclin E Prostate-Specific Antigen Antineoplastic Agents, Phytogenic Tamoxifen DNA-Binding Proteins Cyclin D1 Cyclin-Dependent Kinase 9 Paclitaxel Nuclear Proteins Protein Kinase Inhibitors Antibodies, Monoclonal Cyclin-Dependent Kinase Inhibitor p21 Enzyme Inhibitors Receptors, Progesterone Antineoplastic Agents, Hormonal Transcription Factors Deoxycytidine Antigens, Neoplasm Receptor, Epidermal Growth Factor Antimetabolites, Antineoplastic MicroRNAs Cyclophosphamide Taxoids Antibodies, Monoclonal, Humanized Cyclin-Dependent Kinase Inhibitor p16 Anticarcinogenic Agents Cyclin D Microtubule-Associated Proteins Phosphatidylinositol 3-Kinases Cyclin-Dependent Kinase 8 Carrier Proteins RNA, Neoplasm Purines DNA Primers Organoplatinum Compounds Ki-67 Antigen Quinazolines Receptors, Androgen Antibiotics, Antineoplastic Membrane Proteins Camptothecin Recombinant Proteins

Analytical, Diagnostic and Therapeutic Techniques and Equipment63

Survival Rate Disease-Free Survival Survival Analysis Early Detection of Cancer Retrospective Studies Follow-Up Studies Neoplasm Staging Kaplan-Meier Estimate Antineoplastic Combined Chemotherapy Protocols Treatment Outcome Prognosis Combined Modality Therapy Prospective Studies Reverse Transcriptase Polymerase Chain Reaction Registries Multivariate Analysis Blotting, Western Gene Expression Profiling Chemotherapy, Adjuvant Risk Assessment Risk Factors Xenograft Model Antitumor Assays Risk Neoplasm Transplantation Predictive Value of Tests Transfection SEER Program Models, Biological Transplantation, Heterologous Immunohistochemistry Proportional Hazards Models Oligonucleotide Array Sequence Analysis Odds Ratio Tumor Burden Clinical Trials as Topic Drug Administration Schedule Cohort Studies Polymerase Chain Reaction Sensitivity and Specificity Disease Models, Animal Neoplasm Grading Tissue Array Analysis Radiotherapy Radiotherapy, Adjuvant Molecular Targeted Therapy Drug Screening Assays, Antitumor Incidence Gene Knockdown Techniques Logistic Models Immunoenzyme Techniques Palliative Care Questionnaires Mammography Reproducibility of Results Confidence Intervals Radiotherapy Dosage Immunotherapy Lymph Node Excision Mastectomy Mammary Neoplasms, Experimental Biopsy Flow Cytometry Real-Time Polymerase Chain Reaction

Psychiatry and Psychology1

Phenomena and Processes48

Cell Survival Graft Survival Gene Expression Regulation, Neoplastic Cell Cycle Apoptosis Time Factors Mutation Phosphorylation Drug Resistance, Neoplasm Cell Proliferation Signal Transduction Cell Division Genetic Predisposition to Disease Risk Down-Regulation Dose-Response Relationship, Drug Transfection Cell Movement RNA Interference G1 Phase Odds Ratio Genotype Up-Regulation DNA Methylation Promoter Regions, Genetic Sensitivity and Specificity Gene Expression Cell Growth Processes Base Sequence Phenotype Enzyme Activation Protein Binding Gene Silencing S Phase Polymorphism, Genetic Genes, Tumor Suppressor Cell Differentiation Genes, p53 Transcription, Genetic Cell Death DNA Damage Genes, BRCA1 Mitosis Germ-Line Mutation Amino Acid Sequence Drug Synergism Genes, Neoplasm Alleles

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena3

Survival National Cancer Institute (U.S.)Quality of Life

Humanities1

Quality of Life

Information Science8

Survival Rate Registries SEER Program Molecular Sequence Data Base Sequence Incidence Questionnaires Amino Acid Sequence

Named Groups2

Survivors European Continental Ancestry Group

Health Care30

Survival Rate Disease-Free Survival Survival Analysis Retrospective Studies Follow-Up Studies Kaplan-Meier Estimate Treatment Outcome Prospective Studies Registries Multivariate Analysis Age Factors Risk Assessment Risk Factors Risk National Cancer Institute (U.S.)Predictive Value of Tests SEER Program Proportional Hazards Models Odds Ratio Clinical Trials as Topic Cohort Studies Sensitivity and Specificity Incidence Logistic Models Palliative Care Questionnaires Reproducibility of Results Confidence Intervals American Cancer Society Sex Factors

Geographicals3

United States Japan China

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Survival Rate Cell Survival Disease-Free Survival Survival Analysis Survival Cyclin-Dependent Kinases Early Detection of Cancer Breast Neoplasms Lung Neoplasms Cyclin-Dependent Kinase 2 Cyclin-Dependent Kinase 5 Graft Survival Ovarian Neoplasms Prostatic Neoplasms Retrospective Studies Cyclin-Dependent Kinase 4 Neoplasm Metastasis Stomach Neoplasms Follow-Up Studies Neoplasm Staging Kaplan-Meier Estimate Antineoplastic Combined Chemotherapy Protocols Colonic Neoplasms Treatment Outcome Gene Expression Regulation, Neoplastic Neoplasm Invasiveness Cell Line, Tumor Prognosis Neoplasms Antineoplastic Agents Pancreatic Neoplasms Cell Cycle Apoptosis Mice, Nude Combined Modality Therapy Time Factors Neoplasm Proteins CDC2-CDC28 Kinases Neoplasm Recurrence, Local Tumor Markers, Biological Mutation Disease Progression Phosphorylation Carcinoma, Squamous Cell Carcinoma, Non-Small-Cell Lung Prospective Studies Reverse Transcriptase Polymerase Chain Reaction Cancer Vaccines Colorectal Neoplasms Carcinoma Registries RNA, Messenger Protein-Serine-Threonine Kinases Multivariate Analysis Drug Resistance, Neoplasm Cell Proliferation Blotting, Western Cyclin-Dependent Kinase 6 Gene Expression Profiling Cyclins Signal Transduction CDC2 Protein Kinase Age Factors Chemotherapy, Adjuvant Cell Cycle Proteins RNA, Small Interfering Cell Division Risk Assessment Adenocarcinoma Proto-Oncogene Proteins Urinary Bladder Neoplasms Risk Factors Genetic Predisposition to Disease Xenograft Model Antitumor Assays Tumor Suppressor Protein p53 Risk Cisplatin Tumor Suppressor Proteins Fluorouracil Receptors, Estrogen Liver Neoplasms Receptor, erbB-2 United States Survivors Uterine Cervical Neoplasms Rectal Neoplasms Cyclin-Dependent Kinase Inhibitor p27 Down-Regulation Neoplasm Transplantation Cell Transformation, Neoplastic National Cancer Institute (U.S.)Esophageal Neoplasms Tumor Cells, Cultured DNA, Neoplasm Dose-Response Relationship, Drug Predictive Value of Tests Transfection SEER Program Models, Biological Cyclin E

No FAQ available that match "survival cancers cdk6"